Assets Cambio Fecha
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
AstraZeneca USD 96.09B 457M 2023-09
Biogen USD 26.84B 1.35B 2023-12
Celldex Therapeutics USD 465.63M 185.37M 2023-12
Clal Biotechnology ILS 182.69M 6.18M 2022-12
Compugen USD 67.61M 9.44M 2023-09
CSL USD 36.23B 786.4M 2023-06
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Grifols EUR 22.06B 631.75M 2023-09
Immunic USD 66.98M 21.76M 2023-09
Incyte USD 6.78B 393.87M 2023-12
Intrexon USD 190.69M 16.84M 2023-09
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Lexicon Pharmaceuticals USD 276.48M 40.24M 2023-09
Ligand Pharmaceuticals USD 787.22M 17.99M 2023-12
Merck USD 106.73B 2.26B 2023-09
Omeros USD 493.07M 34.35M 2023-09
Regulus Therapeutics USD 37.75M 5.9M 2023-09
Takeda JPY 14.87T 79.15B 2023-09



Regulus Therapeutics Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.